Contract 75N92019C00006
Rho Federal Systems Division Inc · Department Of Health And Human Services · September 16, 2021
Rho Federal Systems Division Inc was awarded a federal contract by Department Of Health And Human Services (National Institutes Of Health) on September 16, 2021 for $3.37 million of work in research and development in the physical, engineering, and life sciences (except nanotechnology and biotechnology). Performance is in Durham, NC. It was awarded under a small business set-aside. The contract has been modified 5 times since the base award It uses cost-plus contract pricing. The most recent modification was on June 29, 2026. If all options are exercised, the contract could reach $25.81 million.
Contract details
- PIID
- 75N92019C00006
- Award type
- Definitive Contract
- Pricing
- Cost Plus Fixed Fee
- Set-aside
- Small Business Set Aside - Total
- Competition
- Full And Open Competition After Exclusion Of Sources
- NAICS
- 541715 · Research And Development In The Physical, Engineering, And Life Sciences (Except Nanotechnology And Biotechnology)
- Product / service
- R&D- Medical: Other (Management/Support)
- Place of performance
- Durham, NC
- First action
- September 16, 2021
- Latest action
- June 29, 2026
Description
CLINICAL RESEARCH OPERATIONS AND MANAGEMENT SUPPORT (CROMS)
Modification timeline
-
June 29, 2026Mod P00019 · Other Administrative Action$25.81M
-
August 27, 2025Mod P00018 · Supplemental Agreement For Work Within Scope$26.37M
-
September 16, 2024Mod P00014 · Supplemental Agreement For Work Within Scope$26.25M
-
August 1, 2024Mod P00013 · Funding Only Action$21.93M
-
July 15, 2024Mod P00012 · Other Administrative Action$22.32M
-
September 16, 2021Mod P00006 · Other Administrative ActionTHE PURPOSE OF THIS ACTION IS TO REALLOCATE FUNDS FOR THE SUBCONTRACTOR FOR CLINICAL RESEARCH OPERATIONS AND MANAGEMENT (CROMS)$13.62M
Similar contracts
| Recipient | Agency | Date | Obligated |
|---|---|---|---|
| Leidos Biomedical Research Inc | Department Of Health And Human Services | July 2, 2026 | $77.58M |
| Leidos Biomedical Research Inc | Department Of Health And Human Services | July 2, 2026 | $8.41M |
| Technical Resources International, Inc. | Department Of Health And Human Services | July 2, 2026 | $39.32M |
| Consolidated Safety Services Incorporated | Department Of Health And Human Services | July 2, 2026 | $465.3K |
| University Of Mississippi Medical Center | Department Of Health And Human Services | July 2, 2026 | $0 |
| Leidos Biomedical Research Inc | Department Of Health And Human Services | July 2, 2026 | $10.12M |
Top contractors in NAICS 541715
Lifetime obligated dollars across all federal contracts in this NAICS code.
| # | Contractor | Contracts | Obligated |
|---|---|---|---|
| 1 | Fluor Marine Propulsion, Llc | 2 | $2.75B |
| 2 | California Institute Of Technology | 240 | $979.40M |
| 3 | The Johns Hopkins University Applied Physics Laboratory Llc | 204 | $482.74M |
| 4 | Lockheed Martin Corporation | 4 | $461.91M |
| 5 | Lockheed Martin Corp | 9 | $317.27M |
| 6 | The Aerospace Corporation | 85 | $308.18M |
| 7 | Fermi Forward Discovery Group, Llc | 1 | $289.92M |
| 8 | Lockheed Martin Corp | 7 | $285.45M |
| 9 | Amentum Technology, Inc. | 4 | $253.24M |
| 10 | The Mitre Corporation | 50 | $222.51M |
Track this on BesaGov
Get a free weekly email when this changes — new awards, new sub-awards, new opportunities. No login required.
Continue learning
Keep researching
Frequently asked questions
What is contract 75N92019C00006?
Contract 75N92019C00006 is a federal contract awarded to Rho Federal Systems Division Inc by Department Of Health And Human Services on September 16, 2021 for $3.37 million of work classified under RESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT NANOTECHNOLOGY AND BIOTECHNOLOGY). It has been modified 5 times since the base award.
Who won contract 75N92019C00006?
Rho Federal Systems Division Inc won contract 75N92019C00006 from Department Of Health And Human Services.
How much is contract 75N92019C00006 worth?
Contract 75N92019C00006 has obligated $3.37 million to date, with a total potential value of $25.81 million if all options are exercised.